VAERS 2021 Database www.vaers.hhs.gov

Main Page | All 2021 Deaths | Videos
VAERS Updated: 10/01/2021
** VAERS DATABASE Last updated: October 1, 2021**
PLEASE CHECK BACK SOON
Download the files above while you wait.






Manufacturers

Total Manufacturer

Incidents per State

State Total
72,296
AK1,638
AL5,339
AR3,412
AS44
AZ13,316
CA58,147
CO11,002
CT7,824
DC1,626
DE1,670
FL36,235
FM3
GA13,429
GU82
HI2,195
IA4,332
ID2,473
IL19,261
IN22,568
KS4,284
KY6,945
LA4,714
MA13,886
MD11,901
ME2,997
MH8
MI17,865
MN11,345
MO8,919
MP30
MS2,676
MT2,147
NC15,401
ND1,273
NE2,732
NH2,859
NJ17,232
NM3,702
NV4,071
NY32,763
OH18,072
OK5,940
OR7,954
PA22,457
PR2,104
QM2
RI1,911
SC6,055
SD1,133
TN8,691
TX34,122
UT4,023
VA13,944
VI49
VT1,661
WA13,811
WI10,395
WV2,220
WY805
XB5
XL1
XV2

ID: 0920147
Sex: F
Age:
State: AZ

Vax Date: 12/18/2020
Onset Date: 12/18/2020
Rec V Date: 01/05/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Nausea; vomiting; pain at injection site with paresthesias in the lower arm; pain at injection site with paresthesias in the lower arm; neck pain on the injection side; severe fatigue; myalgia; Fever; chills; SOB on exertion; This is a spontaneous report from a contactable physician reporting for herself. A 42-year-old female patient received 1st dose of bnt162b2 (BNT162B2, Manufacturer Pfizer-BioNTech, lot# EH9899), via an unspecified route of administration at arm left, on 18Dec2020 at 02:30 PM, at single dose, for COVID-19 immunisation. Medical history included hypertension, obesity, mood disorder, latex allergy. Patient did not experience COVID-19 before vaccination. Concomitant medications included trazodone (unknown manufacturer), escitalopram (unknown manufacturer). On 18Dec2020 at 10:00 PM the patient experienced nausea with outcome of recovering, vomiting with outcome of recovering, pain at injection site with paresthesias with outcome of recovering, neck pain on the injection side with outcome of recovering, severe fatigue with outcome of recovering, myalgia with outcome of recovering, fever with outcome of recovering, chills with outcome of recovering, shortness of breath (SOB) on exertion with outcome of recovering. The patient underwent lab tests and procedures which included COVID-19 PCR test (nasal swab): negative on 25Dec2020. No therapeutic measures were taken as a result of the events. The events were considered non serious.

Other Meds: ;

Current Illness:

ID: 0920148
Sex: F
Age:
State: AZ

Vax Date: 12/27/2020
Onset Date: 12/27/2020
Rec V Date: 01/05/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: aches/pains/body aches and pains; hot flashes; a little fever/fever of a little over 100; she was freezing/chills; cold was worse; couldn't get comfortable; started feeling bad when she went to bed; This is a spontaneous report from a contactable consumer (patient's husband). A 61-year-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/lot number: EH9899), via an unspecified route of administration on 27Dec2020 at 12:45 on Left Upper Arm at single dose for COVID-19 immunization in hospital. No additional vaccines administered on same date of bnt162b2. The patient medical history included she may be a little overweight, but she was not obese. Concomitant medications included bupropion hydrochloride (WELLBUTRIN), levothyroxine sodium (SYNTHROID), lubiprostone (AMITIZA) for stomach. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient previously had the flu shot (influenza vaccine) in the past for immunization and got sick once afterward, she was not sure if it was food poisoning or the flu vaccine, she didn't get one this year. Patient's husband reported that patient got the vaccine yesterday (27Dec2020). She felt fine all day but started feeling bad when she went to bed on 27Dec2020. She was experiencing aches, pains hot flashes and a little fever a little over 100. She had a miserable night. She had body aches and pains, hot flashes and a little fever started around one in the morning of 28Dec2020. The fever was a little over one hundred. It looked like she what she got was normal side effects. The reporter didn't know how long approximately and how high her fever could get before he called the doctor. She had started to feel better on 28Dec2020. Then she was down again. She didn't feel great when she went to bed and then was up from 1AM to 2AM until now (28Dec2020). From 1AM or 2AM until 7AM or 8AM of 28Dec2020 it was the worse with bad aches and pains. She couldn't get comfortable. Alternating between fever and chills. Around 8AM to 9AM it started to get less and the aches started to get less. She didn't have a fever and he had checked 4 or 5 times. Around 2:00PM on 28Dec2020 she had the fever of a little over 100. The hot flashes were moderate to severe. The cold was worse and she was freezing in the middle of the night on 28Dec2020. He gave her heating pads and blankets and she was still freezing. Reporter thought the second shot would be worse with reactions. She was concerned about getting the second shot. No event required a visit to Emergency Room or Physician Office. No Investigation Assessment provided. The outcome of the events was unknown. This report was reported as non-serious.

Other Meds: WELLBUTRIN; SYNTHROID; AMITIZA

Current Illness:

ID: 0920149
Sex: U
Age:
State: IA

Vax Date: 12/15/2020
Onset Date: 12/27/2020
Rec V Date: 01/05/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Positive rapid test and PCR test after 1st vaccination; Positive rapid test and PCR test after 1st vaccination; This is a spontaneous report from a contactable nurse reporting for her/himself. A patient of unspecified age and gender received the 1st dose of bnt162b2 (BNT162B2), via an unspecified route of administration, on 15Dec2020, at single dose, for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient tested positive on 27Dec2020 on a rapid test and on 28Dec2020 on a respiratory panel by PCR. Next dose was scheduled on 05Jan2021. The information on the lot/batch number has been requested.; Sender's Comments: Based on the information available, a possible contributory role of the suspect BNT162B2 cannot be excluded for the reported event Positive rapid test and PCR test based on the known safety profile. However the short duration of 12 days since the vaccine first dose is given it is unlikely patient would have fully developed immunity.

Other Meds:

Current Illness:

ID: 0920150
Sex: F
Age:
State: MA

Vax Date: 12/17/2020
Onset Date: 12/17/2020
Rec V Date: 01/05/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Severe left arm pain; loss/dulling of taste within 1hr of vaccine that lasted 12hrs; loss/dulling of taste within 1hr of vaccine that lasted 12hrs; joint pain; tiredness; This is a spontaneous report from a contactable nurse (patient). A 42-year-old female patient (not pregnant) received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number: EH9899), via an unspecified route of administration in left arm on 17Dec2020 07:45 at single dose for covid-19 immunization. The COVID-19 vaccine was administered at Hospital. There was no medical history. Concomitant medication in two weeks included vitamin d3, cyanocobalamin (B12). The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient experienced severe left arm pain; loss/dulling of taste within 1hr of vaccine that lasted 12hrs; joint pain and tiredness on 17Dec2020 at time of 09:00 AM. No treatment received for these events. Prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination, the patient was not been tested for COVID-19. The outcome of events was recovered in Dec2020.

Other Meds: VITAMIN D3; B12 [CYANOCOBALAMIN]

Current Illness:

ID: 0920151
Sex: F
Age:
State: NY

Vax Date: 12/22/2020
Onset Date: 12/24/2020
Rec V Date: 01/05/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: tested positive for coronavirus; tested positive for coronavirus; This is a spontaneous report from a contactable physician (patient). A female patient of an unspecified age received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 22Dec2020 at single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient experienced tested positive for coronavirus on 24Dec2020. The patient worked in a hospital. She got the first dose of Pfizer coronavirus vaccine on Tuesday, 22Dec2020. She tested positive for coronavirus on Thursday 24Dec2020 after exposure to patients and staff. She had mild symptoms. Her 2nd dose was scheduled for 12Jan2021. The patient was inquiry whether she should receive it, or should she take an antibody test first, but it would be less than 3 weeks from the onset of illness. The outcome of event was unknown. Information on the lot/batch number has been requested.; Sender's Comments: Based on the information available, a possible contributory role of the suspect BNT162B2 cannot be excluded for the reported event tested positive for coronavirus based on the known safety profile. However the short duration of 2 days since the vaccine first dose is given it is unlikely patient would have fully developed immunity.

Other Meds:

Current Illness:

ID: 0920152
Sex: F
Age:
State: ID

Vax Date: 12/18/2020
Onset Date: 12/20/2020
Rec V Date: 01/05/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: I have had mild tenderness and what I would describe as a burning sensation around the T1-T3 dermatome area, on the same side as my injection, beginning approximately 1-2 days post vaccination.; I have had mild tenderness and what I would describe as a burning sensation around the T1-T3 dermatome area, on the same side as my injection, beginning approximately 1-2 days post vaccination.; feeling like prodromal shingles pain though she never personally had shingles; This is a spontaneous report from a contactable other healthcare professional (patient herself). A 35-year-old female patient received first dose of BNT162B2, intramuscular (right arm), on 18Dec2020 at 11:00, at a single dose, for COVID-19 vaccination. Medical history included allergies to penicillin. The patient's concomitant medications were not reported. On 20Dec2020, the patient had mild tenderness and would describe as a burning sensation around the T1-T3 dermatome area, on the same side of her injection, beginning approximately 1-2 days post vaccination. She was feeling like prodromal shingles pain though she never had shingles. Patient is currently on 10th day post vaccination and continues to have this sensation and mild tenderness but have yet to develop any shingles rash. The patient did not receive treatment for events "I have had mild tenderness and what I would describe as a burning sensation around the T1-T3 dermatome area, on the same side as my injection, beginning approximately 1-2 days post vaccination." Outcome of the event pain was unknown, while for the remaining events was recovering. Information about lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 0920153
Sex: F
Age:
State: TX

Vax Date: 12/27/2020
Onset Date: 12/27/2020
Rec V Date: 01/05/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Fever 101.5; body aches; chills; headache; This is a spontaneous report from a contactable other health professional (patient). A 32-year-old female patient (not pregnant at the time of vaccination) received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL0140), intramuscular on 27Dec2020 08:45 at single dose at right arm for COVID-19 immunization. Medical history reported as none, no Allergies to medications, food, or other products. Concomitant medication was none, the patient did not receive any medications within 2 weeks of vaccination. Facility where the most recent COVID-19 vaccine was administered at Hospital. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 27Dec2020 21: 30 (09:30 PM), the patient experienced fever 101.5, body aches, chills, headache. Treatment received for the adverse events included Tylenol. Prior to vaccination, the patient wasn't diagnosed with COVID-19. Since the vaccination, the patient hadn't been tested for COVID-19. The outcome of the events was not recovered.

Other Meds:

Current Illness:

ID: 0920154
Sex: F
Age:
State:

Vax Date: 12/28/2020
Onset Date: 12/28/2020
Rec V Date: 01/05/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: pain between her right scapula and spine; pain between her right scapula and spine; This is a spontaneous report from a contactable nurse (patient herself). A 22-year-old female patient started to receive BNT162B2 (lot number: EJ1685; expiry date unknown) intramuscular (right arm), on 28Dec2020, at a single dose, for COVID-19 vaccine injection/ vaccination. The patient's medical history and concomitant medications were not reported. This nurse was administered her first dose of Pfizer COVID-19 Vaccine on 28Dec2020, in the morning. Her first concern was that the nurse put the COVID-19 Vaccine injection really low into her right arm, but believes it did go into the muscle. She was concerned that it did not really go into her muscle but the more she has been lifting her arm and seeing where the shot was administered and where her muscle in her arm ends she believes it did go into the muscle. She contacted her primary care provider today because about 30 minutes to 1 hour after she was administered the COVID-19 vaccine injection on 28Dec2020 she had a pain in between her right scapula and spine, which is the side she got her vaccine on. She also reported that her right arm does not hurt at all, she has no pain at injection site for COVID-19 Vaccine which she finds really weird. She also felt the pain if she hunches her shoulders backwards, sits up really straight, crosses her arms or hunches forward; she does not really feel it if she takes a deep breath. She was wondering if these events are normal or expected or serious. Outcome of the events was not recovered.

Other Meds:

Current Illness:

ID: 0920155
Sex: F
Age:
State:

Vax Date: 12/22/2020
Onset Date: 12/23/2020
Rec V Date: 01/05/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Left with nasty scab; Hand was wet from where she had scratched/busted open water blisters on her hand; A rash and hives on that hand/rash unilaterally from the vaccination-side armpit to her breast and collar bone; A rash and hives on that hand; This is a spontaneous report from a contactable other health professional (patient). A 39-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 22Dec2020 at 14:00 at single dose for COVID-19 immunization. The patient medical history included breast cancer survivor, radiotherapy, psoriasis, pre-diabetic, hypertension, hypercholesterolemia and chronic obstructive pulmonary disease (COPD), all from an unknown date and unknown if ongoing. The patient's concomitant medications were not reported. The patient reported that: " on 23Dec2020 at 6:00, she woke up and her hand was wet from where she had scratched/busted open water blisters on her hand (same arm that she received the vaccine in). She also reported a rash and hives on that hand, and a rash unilaterally from the vaccination-side armpit to her breast and collar bone but nothing at injection site. She stated she took BENADRYL, symptoms subsided until BENADRYL wore off, then resurfaced, took more BENADRYL, then symptoms resolved. Symptoms lasted about 24 hours post injection, patient was left with a "nasty scab" on her hand from where she scratched the water blisters". The patient outcome of the events was recovered except for the "nasty scab" whose outcome was not recovered. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 0920156
Sex: U
Age:
State:

Vax Date: 12/14/2020
Onset Date: 12/01/2020
Rec V Date: 01/05/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: tested positive for covid; tested positive for covid; This is a spontaneous report from a Pfizer-sponsored program Pfizer First Connect. A contactable Pharmacist reported similar events for 2 patients. This is the first of two reports. A patient of unspecified age and gender received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration on 14Dec2020 at single dose for covid-19 immunization. The patient medical history and concomitant medications were not reported. Caller is a pharmacist asked if there is a contraindication for administering antibody therapy to a person after they have received the first dose of the covid vaccine. He reported that there are 2 patients that received the covid vaccine the week of 14Dec and subsequently tested positive for covid on the 23rd and 24th of December. He was trying to determine the safety of administering antibody therapy for those patients even though they already got the first vaccine dose. He reported this question has some urgency and needed the information within 48 hours. Attempted to warm transfer but caller reported that he does not have any patient specific information or identifiers at this time. Escalating Urgently for additional research. Outcome of event was unknown. Information on the lot/batch number has been requested.; Sender's Comments: Based on the limited available information, the company considers that a causal relationship between the event "tested positive for COVID" and vaccination with BNT162B2 cannot be excluded.,Linked Report(s) : US-PFIZER INC-2020516661 same reporter/ drug/ AE, different patient

Other Meds:

Current Illness:

ID: 0920157
Sex: M
Age:
State: AR

Vax Date: 12/16/2020
Onset Date:
Rec V Date: 01/05/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: meningitis; headache; fever; weakness; rash; This is a spontaneous report from a contactable consumer (patient). A male patient of an unspecified age received bnt162b2 (lot/batch number and expiration date not provided), via an unspecified route of administration, on 16Dec2020, at single dose, for COVID-19 immunization. The patient medical history and concomitant medications were not reported. The patient received the Pfizer-BioNTech COVID-19 Vaccine on 16Dec2020, he experienced headache, fever, weakness and rash; went to the ER and after testing blood work and suspecting of meningitis. They did a spinal tap. Test came out negative for Flu and COVID; was told the rash could be due to a drug reaction and they attributed side effects to a generic bactrim, so he stopped taking all medications. If he continues to have issues the primary concern is whether he should get the second dose of the COVID-19 vaccine or not. The outcome of the events were unknown. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 0920158
Sex: M
Age:
State: NM

Vax Date: 12/23/2020
Onset Date: 12/24/2020
Rec V Date: 01/05/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: soreness in left arm the following day along with fatigue and body aches; soreness in left arm the following day along with fatigue and body aches; soreness in left arm the following day along with fatigue and body aches; This is a spontaneous report from contactable other healthcare professional. A 33-year-old male patient received first dose of BNT162B2 (lot number: EH9899; expiry date: unknown) intramuscular (left arm), on 23Dec2020 at 14:00, at a single dose, for COVID-19 vaccination. The patient had no relevant medical history. The patient had no known allergies. The patient's concomitant medications were not reported. The patient experienced soreness in left arm the following day (24Dec2020) at 8:00 a.m. along with fatigue and body aches. The patient did not receive treatment for the events. The patient recovered from the events on an unspecified date in Dec2020.

Other Meds:

Current Illness:

ID: 0920159
Sex: F
Age:
State: MO

Vax Date: 12/28/2020
Onset Date: 12/28/2020
Rec V Date: 01/05/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Tingling in throat; throat swelling; This is a spontaneous report from a contactable nurse (patient herself). A 52-year-old female patient received first dose of BNT162B2 (lot number: EH9899; expiry date: 31Mar2021), via an unspecified route of administration, on 28Dec2020 10:00 am (left arm), at a single dose, for COVID-19 vaccination. Relevant medical history included hypertension and seasonal allergies. Concomitant medication included levocetirizine dihydrochloride (XYZAL). The patient previously took losartan, sulfa, ultram, morphine, codiene, and lisinopril and experienced allergies. On 28Dec2020, at 10:15 a.m., the patient experienced tingling in throat and throat swelling. The patient received Benadryl as treatment for the events. Outcome of the events was recovering.

Other Meds: XYZAL

Current Illness:

ID: 0920160
Sex: F
Age:
State: TN

Vax Date: 12/28/2020
Onset Date: 12/28/2020
Rec V Date: 01/05/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Vomiting; chills; Diarrhea; Nausea; fatigue; This is a spontaneous report from a contactable nurse(patient). A 34-year-old female patient received first dose BNT162B2 (lot number: EL0140), via an unspecified route of administration on 28Dec2020 07:00 at 34 years old at single dose at Left arm for COVID-19 immunization. Medical history included Migraines, asthma, chronic bronchitis, PCOS, Allergies to Penicillin. The concomitant medications were biotin, bifidobacterium infantis, lactobacillus acidophilus(PROBIOTIC), Multivitamin, vitex agnus castus. The patient previously took codeine and experienced allergies. Nausea and fatigue beginning about four hours after administration on 28Dec2020 11:00. Diarrhea beginning about six hours after administration on 28Dec2020 13:00. Vomiting and chills beginning about eight hours after administration on 28Dec2020 15:00. There was no treatment received for the adverse event. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The outcome of the events was Recovering.

Other Meds: ; PROBIOTIC [BIFIDOBACTERIUM INFANTIS;LACTOBACILLUS ACIDOPHILUS]; VITEX AGNUS CASTUS

Current Illness:

ID: 0920161
Sex: F
Age:
State: TX

Vax Date: 12/27/2020
Onset Date: 12/27/2020
Rec V Date: 01/05/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Body aches; chills; redness and pain in injection site; redness and pain in injection site; headache; This is a spontaneous report from a contactable other hcp (patient). A 28-year-old female patient received bnt162b2 (lot number: EL0140), intramuscularly at arm right, first dose on 27Dec2020 10:15, at single dose for COVID-19 immunization. Medical history included polycystic ovarian syndrome (PCOS) and hypertension from an unknown date. The patient was not pregnant. No known drug allergies. Concomitant medication included losartan, and metformin. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. The patient experienced body aches, chills, redness and pain in injection site, headache on 27Dec2020 12:00. Therapeutic measures were taken as a result of body aches, chills, redness and pain in injection site, headache, treatment included Tylenol. The events were reported as non-serious. The outcome of the events was not recovered.

Other Meds: ;

Current Illness:

ID: 0920162
Sex: F
Age:
State: NJ

Vax Date: 12/18/2020
Onset Date: 12/19/2020
Rec V Date: 01/05/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: High fevers (103/104 degree F) with chills for five days followed by low fevers ( upto 101) for another six days and still ongoing; High fevers (103/104 degree F) with chills for five days followed by low fevers ( upto 101) for another six days and still ongoing; headaches; fatigue; This is a spontaneous report from a contactable physician, the patient. A 49-year-old non-pregnant female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN), via an unspecified route of administration in the left arm on 18Dec2020 at 15:15 (at 49-years-old) as a single dose for COVID-19 immunization. Medical history included severe iron deficiency, hypothyroidism, osteoporosis, and low baseline IgM antibodies levels (unknown cause). The patient did not have any allergies to medications, food, or other products. Concomitant medications included gabapentin (MANUFACTURER UNKNOWN), iron (MANUFACTURER UNKNOWN), calcium (MANUFACTURER UNKNOWN), and biotin (MANUFACTURER UNKNOWN). The patient did not receive any other vaccines within four weeks prior to the vaccination. On 19Dec2020 at 18:00, the patient experienced high fevers (103/104 degrees Fahrenheit) with chills for five days followed by low fevers (up to 101 degrees Fahrenheit) for another six days, headaches, and fatigue; all reported as non-serious. On 24Dec2020, the patient had a post vaccination nasal swab rapid antigen test and SARS-CoV-2 PCR test with negative results. The patient took paracetamol (TYLENOL) and ibuprofen (ADVIL) for treatment for the events. The clinical outcomes of the fever, chills, headaches, and fatigue were recovering. The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow up.; Sender's Comments: Based on the compatible temporal association and the drug's known safety profile, the vaccination with BNT162B2 might play a contributory role in triggering the onset of high fevers with chills. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.

Other Meds: ; ; ;

Current Illness:

ID: 0920163
Sex: M
Age:
State:

Vax Date: 12/26/2020
Onset Date: 12/26/2020
Rec V Date: 01/05/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: mild fever; body and joint aches; body and joint aches; This is a spontaneous report from a non-contactable physician. A 45-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), lot number: EK9231, an unspecified route of administration, from 26Dec2020 at a single dose, for COVID-19 immunization. Medical history included penicillin allergies. The patient's concomitant medications were not reported. On 26Dec2020 20:00, the patient experienced mild fever and "body and joint aches", lasted for 24 hours. Therapeutic measures were taken as a result of the events included tylenol and advil. The outcome of events was recovered. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 0920164
Sex: F
Age:
State:

Vax Date: 12/21/2020
Onset Date: 12/26/2020
Rec V Date: 01/05/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: tested positive for Covid; tested positive for Covid; This is a spontaneous report from a contactable other healthcare provider. A 44-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration at single dose on 21Dec2020 for Covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient said that she received the Pfizer-BioNTech Covid-19 Vaccine last Tuesday, 21Dec2020, then tested positive for Covid on 26Dec2020. She said the symptoms started on 24Dec2020. Now, she wants to know if it is still okay to get the 2nd dose of the vaccine on the scheduled date. The outcome of events was unknown. Information about Lot/Batch number has been requested.; Sender's Comments: Based on the limited available information, the company considers that a causal relationship between the event "tested positive for COVID" and vaccination with BNT162B2 cannot be excluded.

Other Meds:

Current Illness:

ID: 0920165
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 01/05/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: had an inflamed lymph node after the vaccine; This is a spontaneous report from a contactable consumer (Pfizer colleague). A female patient of an unspecified age received bnt162b2 (BNT162B2; solution for injection; unknown lot number and expiration date), via an unspecified route of administration on an unspecified date at single dose for Covid-19 vaccination. The patient's medical history and concomitant medications were not reported. The reporter stated that her family friend reported that she had an inflamed lymph node after the vaccine. She said that she already did the vsafe but didn't say anything about the reaction to the vaccine. The patient inquired if there was another website that she needs to report to which the reporter replied that VAERS is the correct place to report. The outcome of the event was unknown. Information about lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 0920166
Sex: M
Age:
State:

Vax Date: 12/21/2020
Onset Date: 12/21/2020
Rec V Date: 01/05/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: tachycardia(HR-90's to 130) for 3 days; injection site discomfort; myalgias; fatigue; This is a spontaneous report from a non-contactable physician (patient). A 46-year-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number EH9899), intramuscular at right arm on 21Dec2020 09:30 at single dose for COVID-19 immunization at a hospital. The patient's relevant medical history was reported as none, other medical history was none. No allergies to medications, food, or other products. Concomitant medications were not reported. No other vaccines within 4 weeks prior to the COVID vaccine. The patient was not diagnosed with COVID-19 prior to vaccination, and had not been tested for COVID-19 since the vaccination. It was reported that the patient got the vaccine on Monday (21Dec2020). On 21Dec2020 13:00, the main symptom that he was having was tachycardia (HR-90's to 130) for 3 days. Only other symptoms were injection site discomfort, myalgias and fatigue. The above events resulted in doctor or other healthcare professional office/clinic visit. No treatment was taken for the above events. The outcome of the events was recovering. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 0920167
Sex: F
Age:
State: IL

Vax Date: 12/26/2020
Onset Date: 12/26/2020
Rec V Date: 01/05/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: runny nose that had bloody discharge; runny nose that had bloody discharge; The mother was 23 weeks pregnant at the onset of the event; pregnancy; pregnancy; This is a spontaneous report from a non-contactable physician (patient). A 36-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: Not available/provided to reporter at the time of report completion) via an unspecified route of administration on 26Dec2020 13:30 on right arm at a single dose for COVID-19 immunization. The patient was allergies for adhesives. The patient is pregnant at the time of vaccination. The mother was 23 weeks pregnant at the onset of the event. The mother was due to deliver on 23Apr2021. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination, the patient has not been tested for COVID-19. Concomitant medication included acetylsalicylic acid (ASPIRIN 81) at 81mg. The patient experienced runny nose that had bloody discharge on 27Dec2020. No treatment received for the event. The outcome of the event was recovered in Dec2020. No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds: ASPIRIN 81

Current Illness:

ID: 0920168
Sex: F
Age:
State: MO

Vax Date: 12/22/2020
Onset Date: 12/23/2020
Rec V Date: 01/05/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: difficulty thinking; brain fog; Injection site pain and swelling; Injection site pain and swelling; axillary lymph node swelling; wrist pain and swelling/joint pain; wrist pain and swelling; muscle and joint pain; skin pain; kidney and liver pain; kidney and liver pain; dizziness; nausea; weakness; fatigue; chilling; This is a spontaneous report from a contactable nurse (patient). A 49-year-old female patient (not pregnant) received first dose bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot/batch number and expiry date were not provided), intramuscular in right arm on 22Dec2020 14:30 at single dose for COVID-19 immunisation. Facility where the most recent COVID-19 vaccine was administered was hospital. Medical history included asthma. Prior to vaccination, the patient was not diagnosed with COVID-19. No allergies to medications, food, or other products. Concomitant medication included fluticasone propionate, salmeterol xinafoate (ADVAIR). The patient experienced Injection site pain and swelling, axillary lymph node swelling, wrist pain and swelling, muscle and joint pain, skin pain, kidney and liver pain, dizziness, nausea, weakness, fatigue, chilling, difficulty thinking, brain fog on 23Dec2020 01:15. Symptoms lasting x 6 days. The patient not received any other vaccines within 4 weeks prior to the COVID vaccine. No treatment received for the adverse event. Since the vaccination, the patient has not been tested for COVID-19. The outcome of events was reported as recovering. Information about lot/batch number are requested.; Sender's Comments: Based on available information, a possible contributory role of the subject product, BNT162B2 vaccine, cannot be excluded for the difficulty thinking, brain fog and other reported events due to temporal relationship. There is limited information provided in this report. Additional information is needed to better assess the case, including complete medical history, diagnostics including head CT/MRI and chemistry panel, counteractive treatment measures and concomitant medications. This case will be reassessed once additional information is available. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.

Other Meds: ADVAIR

Current Illness:

ID: 0920169
Sex: F
Age:
State: GA

Vax Date: 12/16/2020
Onset Date: 12/16/2020
Rec V Date: 01/05/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: itchy flushed skin with a rash; itchy flushed skin with a rash; itchy flushed skin with a rash; This is a spontaneous report from a contactable healthcare professional. A 45-year-old female patient received bnt162b2 (BNT162B2; reported as Pfizer-Bio-Tech COVID-19 Vaccine; lot number: EH9899; expiration date: unknown), intramuscular left arm on 16Dec2020 10:45 (also reported as 10:50 AM) at single dose for Covid-19 vaccination. The patient's medical history and concomitant medications were not reported. It was unknown if the patient has allergies to medications, food, or other products. It was reported that the patient was given vaccine at 10:50 am and 10 minutes after receiving the vaccine individual developed itchy flushed skin with a rash. She was given Benadryl 50 mg IM (intramuscular) in Right arm at 11:00 am. 11:37 am the itchy skin was less intensified, and vitals were stable. The patient went home with her husband. The event was considered as non-serious, was not life-threatening, did not caused/prolonged hospitalization, did not cause congenital anomaly/birth defect and did not resulted to death. The patient received the COVID-19 vaccine in the Clinic. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. It was unknown if the patent had any other medications the patient received within 2 weeks of vaccination. It was unknown if the patient diagnosed with COVID-19 prior to vaccination and if the patient been tested for COVID-19 since the vaccination. The outcome of the event itchy skin was recovering while the outcome of the other events was unknown. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 0920171
Sex: F
Age:
State: MI

Vax Date: 12/23/2020
Onset Date: 12/23/2020
Rec V Date: 01/05/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Sometimes her headaches are migraines; Chills; Fever; Cough; Really lazy; Body aches; Headache; Nausea; This is a spontaneous report from a contactable Registered nurse (patient). A 50-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/lot number: E10140), via an unspecified route of administration on 23Dec2020 15:00 at single dose for COVID-19 immunization. Medical history included ongoing Diabetic for at least 7 years, ongoing hit in the head (She was a psych nurse and was hit in the head at work maybe a month to two months ago in 2020. She did have headaches from that incident). There were no concomitant medications. The patient experienced headache on 23Dec2020, fever on 24Dec2020 14:30, nausea on 23Dec2020, cough on 24Dec2020, really lazy on 24Dec2020, chills on 24Dec2020 14:30, body aches on 24Dec2020, sometimes her headaches were migraines on an unspecified date. Specifically, it was reported that when she first got the vaccine, she didn't have anything but a headache and a little bit of nausea. She had worked the night before and didn't sleep before the shot. So maybe that had a part in it. She was a diabetic. It was fine, and no big deal that night. Then, the next day on 24Dec2020 at 2:30 pm she woke up and she was freezing and couldn't get warm. She had chills and a fever of 102.1 on 24Dec2020. She took Tylenol, and it came down to 101 on an unspecified date in Dec2020. All weekend long, she has had a fever. It has been controlled by Tylenol. She had chills so bad she had to use her heated blanket. She has had a cough. She has been really lazy. She has had chills and body aches. She has had nausea here and there. She has had a headache. She received the vaccine on the 23Dec2020, which was Wednesday. She had to stay 15 minutes after. That is when she developed the headache and nausea. Sometimes her headaches were migraines. She developed the fever on 24Dec2020 14:30. Or noticed the fever when she woke up. Her fever was 101.2 this morning on 28Dec2020. Within the 15 minutes of getting the vaccine, she developed the nausea. It has gotten better. Her body aches are getting better. She still has chills when she is running a fever. She has gotten better overall. Thursday (24Dec2020), Friday (25Dec2020), and Saturday (26Dec2020) it was awful. Sunday (27Dec2020) the symptoms lightened up. Today (28Dec2020) she was better. She still had a headache and fever this morning, but nothing like she had been feeling. She felt like dying those days. She was a Psych nurse, and she got hit in the head. So she did get headaches from that incident. They are about the same as these headaches so she didn't know if it was related. It just went along with the flu like symptoms. But sometimes these headaches were migraines. Therapeutic measures were taken as a result of fever and chills. The outcome of the events headache, chills was not recovered. The outcome of the event really lazy was recovered on 27Dec2020. The outcome of the events fever, nausea, cough, body aches was recovering. The outcome of the event migraines was unknown.

Other Meds:

Current Illness: Diabetic (At least 7 years); Head injury (She is a psych nurse and was hit in the head at work. She did have headaches from that incident)

ID: 0920172
Sex: F
Age:
State: PA

Vax Date: 12/23/2020
Onset Date: 12/25/2020
Rec V Date: 01/05/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: rash, hives type things on face/rash on the face after the COVID vaccine; rash, hives type things on face; This is a spontaneous report from a contactable consumer (patient herself). A 64-year-old female patient received BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine, Solution for injection; NDC/UPC/batch/lot number and expiration date were unknown), via an unspecified route of administration on 23Dec2020 at a single dose for COVID-19 immunization administered at the hospital. The patient had no medical history. Concomitant medications included mometasone furoate (ASMANEX) inhaler, pramipexole, simvastatin, montelukast, and gabapentin. The patient stated that she didn't know if she was having side effects from the vaccine or not since for the last three days, she had been getting almost like a rash, hives type things on face; nowhere else, just on her face from 25Dec2020. The patient believed it just started in the last couple of days and it didn't happen right at first and wanted to know what it's from. The patient considered herself as a first responder as she worked at the court house and did protection from abuse orders for people in domestic violence situations. The patient was still experiencing the problems and seemed to happen in the afternoon, every afternoon she seemed to get it. The patient further reported that she experienced rash on the face after the COVID vaccine and it happened in the afternoon. She got the COVID (19) vaccine on Wednesday and on Friday afternoon (also reported as the "25th, Christmas day"), she experienced rash on the face; she said it was not bad, but it happened in the afternoon. She still had it at the time of the report and it's just on her face. The patient did not receive any treatment for the events. The patient had no investigation assessment. The patient was not recovered from the events "rash, hives type things on face/rash on the face after the COVID vaccine." Information on the batch/lot number has been requested.

Other Meds: ASMANEX; ; ; ;

Current Illness:

ID: 0920173
Sex: F
Age:
State: CA

Vax Date: 12/21/2020
Onset Date: 12/22/2020
Rec V Date: 01/05/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: nausea; diarrhea; upset stomach; This is a spontaneous report from a contactable nurse (patient herself). A 41-year-old female patient received the first dose of BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine, Solution for injection; lot number: EH9899, expiration date: unknown), intramuscularly on the right arm on 21Dec2020 at 07:15 at a single dose for COVID-19 immunization administered at the hospital. Relevant medical history included asthma. The patient had no known allergies; no allergies to medications, food, or other products. Concomitant medications included montelukast sodium (SINGULAIR) and budesonide, formoterol fumarate (SYMBICORT). Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient was not pregnant at the time of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 22Dec2020 at 06:00, the patient experienced nausea, diarrhea, and upset stomach, which were assessed as non-serious. The patient did not receive treatment for the adverse events. The patient was recovering from the events "nausea, diarrhea, and upset stomach."

Other Meds: SINGULAIR; SYMBICORT

Current Illness:

ID: 0920174
Sex: F
Age:
State: PA

Vax Date: 12/23/2020
Onset Date: 12/24/2020
Rec V Date: 01/05/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: developed 2 more of the same type of sores on inside of my cheek, in mouth; sore under top lip; headache; nausea; fatigue; This is a spontaneous report from a contactable nurse (patient). A 38-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 23Dec2020 12:00 PM, at left arm, at single dose for covid-19 immunization. Medical history included hepatitis c from an unknown date and unknown if ongoing. Concomitant medication included fluoxetine hydrochloride (PROZAC), amfetamine aspartate, amfetamine sulfate, dexamfetamine saccharate, dexamfetamine sulfate (ADDERALL). The patient was not pregnant at the time of vaccination. First day on 24Dec2020 the patient had headache and fatigue, some nausea. Day 3 (26Dec2020) and 4 (27Dec2020) headaches all day, mild. Day 5 (28Dec2020) developed sore under top lip and day 6 (29Dec2020) developed 2 more of the same type of sores on inside of my cheek, in mouth. No treatment was received for all events. The outcome of the events was not recovered. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. No seriousness criteria: no Results in death, no Life threatening, no Caused/prolonged hospitalization, no Disabling/Incapacitating, no Congenital anomaly/birth defect. Information about lot/batch number has been requested.

Other Meds: PROZAC; ADDERALL

Current Illness:

ID: 0920175
Sex: M
Age:
State: CA

Vax Date: 12/22/2020
Onset Date: 12/27/2020
Rec V Date: 01/05/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: right side axillary lymph node swollen; This is a spontaneous report from a contactable other healthcare professional (HCP). A 27-year-old male patient (a registered nurse) received the first dose of BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine, Solution for injection; batch/lot number: EK5730, expiration date: unknown), via an unspecified route of administration via injection to the right deltoid on 22Dec2020 at a single dose for COVID-19 immunization as he was working in a high risk patient population in the intensive care unit (ICU). The patient had no medical history. There were no concomitant medications. On 27Dec2020, the patient experienced right side axillary lymph node swollen, which was assessed as non-serious. It was further reported that the patient developed symptoms and stated at the injection site, he had a swollen lymph node, and he called his primary care physician; they did a telehealth visit, and he also reported to the hospital where he received the vaccine and he wanted to fulfill his reporting responsibilities and report to Pfizer, since he had received the vaccine. The patient further clarified the location and stated that the injection site was in the shoulder, but the lymph node was the same side, the axillary lymph node; it was not at the site, it was the axillary lymph node on the right side. The patient had no investigation assessment. The patient was not recovered from the event "right side axillary lymph node swollen." The causal relationship of the drug to the event "right side axillary lymph node swollen" was assessed by the reporting HCP as related; method of assessment: Global Introspection.

Other Meds:

Current Illness:

ID: 0920176
Sex: F
Age:
State: AZ

Vax Date: 12/26/2020
Onset Date: 12/26/2020
Rec V Date: 01/05/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: tongue swell; This is a spontaneous report from a contactable consumer (patient herself; a therapist, but was not clarified). A 35-year-old female patient received the first dose of BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine, Solution for injection; batch/lot number: EK5730, expiration date: unknown), via an unspecified route of administration on 26Dec2020 at a single dose for COVID-19 immunization administered at the workplace. Relevant medical history included bipolar II disorder, hand tremors, and sleep (disorder). Concomitant medications included lithium and lamotrigine (LAMICTAL), both for bipolar II disorder; carbidopa, levodopa for hand tremors; and trazodone for her sleep. The patient had the vaccination and her tongue swelled on 26Dec2020, probably about 15 minutes after she had the shot. The patient had no investigation assessment. In response to the event, the patient had taken diphenhydramine (BENADRYL) at 25 mg, once; just one time. The outcome of the event was unknown.

Other Meds: ; LAMICTAL; CARBIDOPA LEVODOPA;

Current Illness:

ID: 0920177
Sex: F
Age:
State: FL

Vax Date: 12/17/2020
Onset Date: 12/01/2020
Rec V Date: 01/05/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: hivers on lower back to side and left leg; joint stiffness over entire body; This is a spontaneous report from a contactable pharmacist. A 54-year-old female patient received the first dose of BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine, Solution for injection; lot number: ett9899, expiration date: unknown), intramuscularly on the left arm on 17Dec2020 at 10:45 at a single dose for COVID-19 immunization administered at the hospital. Relevant medical history included hypertension, diabetes, tachycardia, diverticulitis, and known allergies to pimentos. Concomitant medications included metformin and metoprolol tartrate (LOPRESSOR). The patient previously took valaciclovir hydrochloride (VALTREX) and experienced allergies to it. The patient was not pregnant at the time of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient experienced hivers on lower back to side and left leg and joint stiffness over entire body on an unspecified date in Dec2020 with hive improvement several days later. The patient received diphenhydramine (BENADRYL) and paracetamol (TYLENOL) orally from the emergency room as treatment for the events. The events resulted in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. The events were assessed as non-serious. The patient recovered from the events "hivers on lower back to side and left leg and joint stiffness over entire body" on an unspecified date in Dec2020.

Other Meds: ; LOPRESSOR

Current Illness:

ID: 0920178
Sex: F
Age:
State: CA

Vax Date: 12/24/2020
Onset Date: 12/01/2020
Rec V Date: 01/05/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: had a severe pain in upper left hip; hurt to lift my left leg up (while taking a step forward); This is a spontaneous report from a contactable nurse (patient). A 45-year-old non-pregnant female patient received first dose of BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine, lot number: EK5730), intramuscular in the left arm on 24Dec2020 08:15AM at a single dose for COVID-19 immunization. The patient was vaccinated in a hospital facility. Medical history included lyme disease from 2014. Prior to vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. The patient did not receive other vaccines in last four weeks. Concomitant medication included ethinylestradiol, ferrous fumarate, norethisterone acetate (LO LOESTRIN FE). On 25Dec2020 07:30AM, the patient had a severe pain in upper left hip. It felt like an IT band issue she had before but this time it didn't radiate to her knee like it usually does. She did not have exercise since the morning of the 22nd when she did an upper body weight-lifting session. She took ibuprofen that took the edge off, and she was able to finish her day as a nurse in the Covid ICU. The following morning, she felt fine and went to her other job. She was fine in the morning during her usual drills practicing getting out of the helicopter while on the ground. She sat in one of the seats for about 15 minutes while having a discussion when she started to feel the pain again. She got out of the helicopter and tried to walk around, but it hurt to lift her left leg up (while taking a step forward) in Dec2020. She has never experienced this before. She limped back to the hanger, took ibuprofen 600mg and rested/stretched for an hour. The pain was reduced to a minor and tolerable ache. The outcome of the events was recovering. The report was considered non-serious.

Other Meds: LO LOESTRIN FE

Current Illness:

ID: 0920179
Sex: F
Age:
State:

Vax Date: 12/23/2020
Onset Date: 12/24/2020
Rec V Date: 01/05/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Weird mental fog where she was lightheaded and dizzy; Weird mental fog where she was lightheaded and dizzy; Taste was diminished as well as her smell; Taste was diminished as well as her smell; Arm soreness; fatigue; This is a spontaneous report from a contactable physician (patient) reported for herself. A female patient of an unspecified age received first dose of BNT162B2, via an unspecified route of administration on 23Dec2020 at single dose for COVID-19 immunization. The patient medical history and concomitant medications were not reported. The physician said she had the first dose of the COVID vaccine on 23Dec2020 (last Wednesday). She had arm soreness and fatigue the next day on 24Dec2020, but it was fine. Over the weekend she had less common symptoms. She had read on blogs that this could be vaccine related. She felt overall very well, but was wondering how long these symptoms should last? Three days after getting the vaccine she had a weird mental fog where she was lightheaded and dizzy on 26Dec2020. It was a weird sensation. She stayed in bed most of the day and did not do much. Saturday and Sunday she felt like her taste was diminished as well as her smell on 26Dec2020. It was still occurring this morning too. It was very noticeable that her taste and smell are diminished. She was wondering how long these things will last? The outcome of the events arm soreness and fatigue was recovered in Dec2020. The outcome of the events taste was diminished as well as her smell was not recovered. The outcome of the other events was unknown. Information on the Batch/Lot number has been requested.

Other Meds:

Current Illness:

ID: 0920180
Sex: M
Age:
State:

Vax Date: 12/18/2020
Onset Date: 12/19/2020
Rec V Date: 01/05/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Severe headache; Nausea; Sweats; Fatigue; This is a spontaneous report from a non-contactable physician. A 38-year-old male patient received first dose bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/lot number: EH9899), intramuscular in arm left on 18Dec2020 08:45 at single dose for COVID-19 immunisation. Facility where the most recent COVID-19 vaccine was administered was hospital. Medical history included eczema. Prior to vaccination, the patient was not diagnosed with COVID-19. Concomitant medication included cetirizine hydrochloride (ZYRTEC). The patient experienced 'Severe headache with nausea Sweats Fatigue' on 19Dec2020 09:00. Case was non-serious. Since the vaccination, the patient has not been tested for COVID-19. The patient not received any other vaccines within 4 weeks prior to the COVID vaccine. Therapeutic measures were taken as a result of events (Tylenol, Naproxen). The outcome of the events was recovered in Dec2020. No follow-up attempts are possible. No further information is expected.

Other Meds: ZYRTEC [CETIRIZINE HYDROCHLORIDE]

Current Illness:

ID: 0920181
Sex: F
Age:
State:

Vax Date: 12/18/2020
Onset Date: 12/01/2020
Rec V Date: 01/05/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Got first vaccine dose on the 18th and came out Covid test positive; Got first vaccine dose on the 18th and came out Covid test positive; This is a spontaneous report from a non-contactable consumer (patient). A female patient of an unspecified age received first dose of BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine; lot/batch number and expiry date were unknown) via an unspecified route of administration on 18Dec2020 at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient got the first dose on the 18th, and she came out Covid test positive yesterday (unspecified date in Dec2020). She wanted to know if she should get the second vaccine or what is the protocol into that. The outcome of the event was unknown. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 0920182
Sex: F
Age:
State: NY

Vax Date: 12/15/2020
Onset Date: 12/23/2020
Rec V Date: 01/05/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Diagnosed with COVID after receiving first dose of COVID-19 Vaccine; Diagnosed with COVID after receiving first dose of COVID-19 Vaccine; This is a spontaneous report from a contactable nurse (patient). A 61-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number PAA156051, expiration date unknown), via an unspecified route of administration on 15Dec2020 16:00 at a single dose at the right arm for COVID-19 immunization. The patient has no medical history, no family medical history and no concomitant medications. The patient is a nurse in the Emergency Room. She had a first dose of COVID-19 vaccine on 15Dec2020. She was diagnosed with COVID after receiving first dose of COVID-19 vaccine on 23Dec2020. Due for second dose of COVID-19 vaccine on 04Jan2021. She wanted to know if she should go through with second dose if her symptoms subside. The COVID swab was done in the Emergency Room and was not admitted to hospital. The outcome of the event was unknown.; Sender's Comments: Based on the information currently available, a lack of efficacy with BNT162B2 in this patient cannot be completely excluded.

Other Meds:

Current Illness:

ID: 0920183
Sex: U
Age:
State:

Vax Date: 12/14/2020
Onset Date: 12/23/2020
Rec V Date: 01/05/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: tested positive for covid; tested positive for covid; This is a spontaneous report from a Pfizer-sponsored program Pfizer First Connect. A contactable Pharmacist reported similar events for 2 patients. This is a 2nd of two reports. A patient of unspecified age and gender received BNT162B2, via an unspecified route of administration on 14Dec2020 at single dose for covid-19 immunization. The patient medical history was not reported. The patient's concomitant medications were not reported. The reporter was a pharmacist asking if there was a contraindication for administering antibody therapy to a person after they had received the first dose of the covid vaccine. He reported that there was a patient that received the covid vaccine the week of 14Dec and subsequently tested positive for covid on the 23rd and 24th of December. The reporter was trying to determine the safety of administering antibody therapy for the patient even though the patient already got the first vaccine dose. The reporter reported this question had some urgency and needed the information within 48 hours. The patient underwent lab tests and procedures which included covid test: positive on 23Dec2020, positive on 24Dec2020. The outcome of the events was unknown. Information on the lot/batch number has been requested.; Sender's Comments: Based on the limited available information, the company considers that a causal relationship between the COVID test positive and vaccination with BNT162B2 cannot be excluded.,Linked Report(s) : US-PFIZER INC-2020516319 same reporter/ drug/ AE, different patient

Other Meds:

Current Illness:

ID: 0920184
Sex: M
Age:
State:

Vax Date: 12/16/2020
Onset Date: 12/16/2020
Rec V Date: 01/05/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: rash; This is a spontaneous report from a non-contactable Other HCP (patient). A 40-year-old male patient received first dose bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/lot number: ek5730), intramuscular in left arm on 16Dec2020 10:00 at single dose for COVID-19 immunisation. Facility where the most recent COVID-19 vaccine was administered was hospital. Medical history included none. No allergies to medications, food, or other products. Prior to vaccination, the patient was not diagnosed with COVID-19. Concomitant medication included influenza vaccine (FLU) on 01Dec2020 at single dose for immunization. The patient experienced rash (non-serious) on 16Dec2020 16:00. Since the vaccination, the patient has not been tested for COVID-19. Therapeutic measures were taken as a result of rash (Benadryl). The outcome of event was recovered in Dec2020. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 0920185
Sex: F
Age:
State: GA

Vax Date: 12/28/2020
Onset Date: 12/28/2020
Rec V Date: 01/05/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Fatigue; muscle soreness at site; muscle ache; mild joint pain; fever 100.1; This is a spontaneous report from a contactable nurse (patient). A 23-year-old female patient (not pregnant at the time of vaccination) received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL0140), via an unspecified route of administration on 28Dec2020 12:00 at single dose at left arm for COVID-19 immunization. Medical history included known allergies: Penicillin, erythromycin. Concomitant medication received in two weeks included melatonin. Facility where the most recent COVID-19 vaccine was administered at Hospital. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 28Dec2020 15:00 (03:00 PM), the patient experienced fatigue, muscle soreness at site, muscle ache, mild joint pain, fever 100.1. Treatment received for the adverse events included Acetaminophen. The events were non-serious per the reporter. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient hadn't been tested for COVID-19. The outcome of the events was recovering. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 0920186
Sex: F
Age:
State:

Vax Date: 12/23/2020
Onset Date: 12/23/2020
Rec V Date: 01/05/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: severe sore arm in limb it was given; nausea; fatigue; This is a spontaneous report from a non-contactable nurse (patient). A 37-year-old non-pregnant female patient received first dose of BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine; batch/lot number and expiry date were unknown), intramuscular in the right arm on 23Dec2020 10:15 at a single dose for COVID-19 immunization. The patient has no other medical history. The patient has no known allergies. The patient has no COVID prior vaccination, and COVID was not tested post vaccination. Concomitant medications included levothyroxine sodium (SYNTHROID), escitalopram oxalate (LEXAPRO), and vitamin c (ascorbic acid). The patient has no other vaccine in the past four weeks. On 23Dec2020 01:00 PM, the patient experienced severe sore arm in limb it was given (by nighttime she was almost unable to use her right arm, improved by next morning), nausea, and fatigue. The outcome of the events was recovered in Dec2020. No treatment was received for the adverse events. The report was considered non-serious. No follow-up attempts are possible; Information about batch/lot number cannot be obtained. No further information is expected.

Other Meds: SYNTHROID; LEXAPRO; VITAMIN C [ASCORBIC ACID]

Current Illness:

ID: 0920187
Sex: M
Age:
State: AZ

Vax Date: 12/28/2020
Onset Date: 12/28/2020
Rec V Date: 01/05/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: mild nausea (on a scale of 1 to 5 ---like 2 to 3); little light headed (2 on a scale of 1 to 5); This is a spontaneous report from a contactable healthcare professional (patient). A 44-year-old male patient received first dose of BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine; lot/batch number and expiry date were unknown), via an unspecified route of administration in the left arm on 28Dec2020 10:00 at a single dose for COVID-19 immunization. Medical history included Epstein Barr, shingles in Oct2020 (2 months previous), detached retina in 2016 (4.5 years ago), and covid prior vaccination. There is no covid test done post vaccination. The patient's concomitant medications were not reported. The patiently previously had allergies to gentamycin. On 28Dec2020 12:00, the patient just had some mild nausea (like 2 to 3 on a scale of 1 to 5) and a little lightheaded (2 on a scale of 1 to 5). There is no treatment received for the adverse events. The outcome of the events was recovering. The report is considered non-serious. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 0920188
Sex: F
Age:
State: WI

Vax Date: 12/28/2020
Onset Date: 12/28/2020
Rec V Date: 01/05/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Dizziness; This is a spontaneous report from a contactable nurse (patient). A 49-year-old non-pregnant female patient received first dose of BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine; batch/lot number and expiry date were unknown), via an unspecified route of administration in the left arm on 28Dec2020 at a single dose for COVID-19 immunization. The patient was vaccinated in a hospital facility. Medical history included COVID-19 prior to vaccination. The patient was not tested for COVID-19 post vaccination. The patient did not receive other vaccines in the last four weeks. Concomitant medications included omeprazole (PRILOSEC), metoprolol, levothyroxine sodium (SYNTHROID), aciclovir sodium (ACYCLOVIR VIAL), and meloxicam (MOBIC). The patient previously had allergies with morphine. On 28Dec2020, the patient experienced dizziness 12 hours after injection with outcome of recovering. The patient did not receive treatment for the reported adverse event. The report was considered non-serious. Information on the batch/lot number has been requested.

Other Meds: PRILOSEC [OMEPRAZOLE]; ; SYNTHROID; ACYCLOVIR VIAL; MOBIC

Current Illness:

ID: 0920189
Sex: F
Age:
State:

Vax Date: 12/28/2020
Onset Date:
Rec V Date: 01/05/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: headaches; kinda unwell; difficulty in finishing sentences; feeling drugged; This is a spontaneous report from a contact physician (patient) from a Pfizer-sponsored program Pfizer First Connect. A female patient of unspecified age received the 1st dose BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration on 28Dec2020 at single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. After taking the Covid-19 vaccine, she's experiencing headaches, kinda unwell, difficulty in finishing sentences, and feeling drugged. Outcome of events was unknown. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 0920190
Sex: M
Age:
State: AL

Vax Date: 12/24/2020
Onset Date: 12/28/2020
Rec V Date: 01/05/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Nausea; Vomiting; Diarrhea; Bad dreams; Extreme chills; Heavy amount of sweating; This is a spontaneous report from a contactable other HCP (patient). A 26-year-old male patient received the first dose of BNT162B2 (lot number: EK5730), via an unspecified route of administration in left arm, on 24Dec2020 09:30 AM at single dose for COVID-19 immunization. Facility where the most recent COVID-19 vaccine was administered was workplace clinic. The patient was not diagnosed with COVID-19 prior to vaccination. Since the vaccination, the patient was not tested for COVID-19. Allergies to medications, food, or other products included Bactrim. Relevant medical history included Kyphosis, Binge Eating Disorder, Anxiety, Depression, ADHD, Obesity, Hypertension, all ongoing. No other vaccines were received within 4 weeks prior to the COVID vaccine. The medications received within 2 weeks of vaccination included omeprazole(PROTONIX), Lisinopril, HCTZ, Atenolol, vilazodone hydrochloride(VIIBRYD). The patient experienced Nausea, Vomiting, Diarrhea, Bad dreams, Extreme chills, Heavy amount of sweating, Elevated motivation to work/be productive, Very optimistic on 28Dec2020 01:00 PM. No treatment was received for the events. The outcome of the events was not recovered.

Other Meds: PROTONIX [OMEPRAZOLE]; ; HCTZ; ; VIIBRYD

Current Illness: ADHD; Anxiety; Binge eating; Depression; Hypertension; Kyphosis; Obesity

ID: 0920191
Sex: F
Age:
State: AK

Vax Date: 12/19/2020
Onset Date: 12/28/2020
Rec V Date: 01/05/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Tenderness, redness, and swollen at injection site. Approximately 2 inches by 1 inch in size.; Tenderness, redness, and swollen at injection site. Approximately 2 inches by 1 inch in size.; Tenderness, redness, and swollen at injection site. Approximately 2 inches by 1 inch in size.; This is a spontaneous report from a contactable other HCP (patient herself). This 28-year-old female received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number EJ1685), via an unspecified route of administration, on 19Dec2020 at 15:00 at single dose for COVID-19 immunisation. Vaccine location was right arm. The patient was not pregnant. Relevant medical history included sinus tachycardia and obstructive sleep apnea. Patient's Body mass index (BMI) is more than 35. No known allergies. Relevant concomitant medications included ibuprofen. The patient was vaccinated at Clinic, age at vaccination was 28-year-old. No other vaccine was received in four weeks. Pre-vaccination and post-vaccination COVID tests were not performed. On 28Dec2020, at 12:30, the patient developed tenderness, redness, and swollen at injection site, approximately 2 inches by 1 inch in size. The patient was not treated for the events. The outcome of the events was unknown. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 0920192
Sex: F
Age:
State: CA

Vax Date: 12/18/2020
Onset Date: 12/19/2020
Rec V Date: 01/05/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Sore arm; nocturnal diaphoresis; generalized mild pain; fatigue; This is a spontaneous report from a contactable nurse (patient). A 42-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot # EJ1685), via an unspecified route of administration, on 18Dec2020 at 02:45 PM at single dose for COVID-19 immunisation. Vaccine location was left arm. The patient was vaccinated at hospital, age at vaccination was 42-years-old. No other vaccine was received in four weeks. Medical history included prior to vaccination the patient diagnosed with COVID-19 and known allergies were Penicillin (PCN), ephedrine, calamine, calendula, pollen. Concomitant medications included escitalopram 10mh. On 19Dec2020 at 07:00 AM, the patient experienced sore arm, nocturnal diaphoresis, generalized mild pain, fatigue. The events were reported as non-serious. The patient recovered in Dec2020 form the events. No treatment was received.

Other Meds:

Current Illness:

ID: 0920193
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 01/05/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Rash all over belly; This is a spontaneous report from a contactable nurse. A female patient of an unspecified age received the bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), via an unspecified route of administration on an unspecified date at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. On an unspecified date, the patient experienced: rash all over belly (non-serious). The clinical outcome of the event was unknown. The batch/lot numbers for the vaccine, PFIZER-BIONTECH COVID-19 MRNA VACCINE, were not provided and will be requested during follow up.

Other Meds:

Current Illness:

ID: 0920194
Sex: M
Age:
State: UT

Vax Date: 12/21/2020
Onset Date: 12/21/2020
Rec V Date: 01/05/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: weak from lack of nutrition; weak from lack of nutrition; Tired; stomach cramps; felt out of breath; nausea; vomiting when exercised; headache; Sore arm; chills; no appetite; clammy hands/clammy hands and feet; very sore at injection site; This is a spontaneous report from a contactable other HCP (patient) reported for himself. A 48-years-old male patient received first dose of BNT162B2, via intramuscular in left arm on 21Dec2020 10:15 AM at single dose for COVID-19 immunization. Facility where the most recent COVID-19 vaccine was administered was hospital. Medical history included known allergies: Shellfish, Corn, Whitefish. The patient's concomitant medications were none. No other vaccine was received within 4 weeks prior to the COVID vaccine. No other medications were received within 2 weeks of vaccination. The patient was not diagnosed with COVID-19 prior vaccination and patient was not tested for COVID-19 since the vaccination. The patient experienced no appetite, clammy hands, very sore at injection site on 21Dec2020 (reported as day 1), sore arm, no appetite, clammy hands and feet, chills on 22Dec2020 (reported as day 2), no appetite, nausea, vomiting when exercised, headache, clammy, chills on 23Dec2020 (reported as day 3), no appetite, nausea, stomach cramps, headache, felt out of breath, clammy, chills on 24Dec2020 (reported as day 4), tired, clammy, headache on 25Dec2020 (reported as day 5) and symptoms resolved but weak from lack of nutrition on 26Dec2020 (reported as day 6). No treatment was received for all the events. The outcome of the events was recovered in Dec2020. The information on the Lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 0920195
Sex: F
Age:
State:

Vax Date: 12/01/2020
Onset Date: 12/01/2020
Rec V Date: 01/05/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: strawberry tongue /taste buds popped up and inflamed like I'd eaten something sour. It was all inflamed; rash the next day and a few days after I got a rash on my chest; This is a spontaneous report from a contactable healthcare professional, the patient. A 38-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN), via an unspecified route of administration in Dec2020 as a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient did not have a history of rash or food allergies. In Dec2020, the patient experienced strawberry tongue and rash. The clinical course was as follows: the patient stated that she believed she had a delayed reaction to the vaccine as it didn't happen within 15 minutes. It happened later on (not further specified). She started to get a strawberry tongue and described it as "taste buds popped up and inflamed like she had eaten something sour." It was all inflamed. She also noticed a rash the next day and a few days after she got a rash on her chest. The clinical outcomes of the strawberry tongue and rash were unknown. The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow up.

Other Meds:

Current Illness:

ID: 0920196
Sex: M
Age:
State: MI

Vax Date: 12/20/2020
Onset Date: 12/01/2020
Rec V Date: 01/05/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: felt a little sick; I got my temperature about 100.2/Fever that I have is 7 days after the vaccine; Had mild body ache; Chills; Usual soreness at the site of injection; Cough; mild sore throat; This is a spontaneous report from a contactable Physician (patient). A 62-year-old male patient received NT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/lot number: EL01-40), via an unspecified route of administration on 20Dec2020 09:30 at single dose for COVID-19 immunization. Anatomical Location provided as Left deltoid. Medical history provided as none. Concomitant medication included hydrochlorothiazide, levothyroxine sodium (SYNTHROID). Physician stated, he got his Pfizer vaccine on last Sunday on 20Dec2020 around 9:30 there was usual soreness at the site of injection on 20Dec2020, which was there but no problem. But Monday (21Dec2020) after his vaccine that was Sunday he had and Monday night on 21Dec2020 he had chills he thought these were all just the reaction to the vaccine. Next day on 22Dec2020 he went into work he had mild body ache at work, at about 3:30 he felt a little sick and he got his temperature about 100.2, get home rested, next day on 23Dec2020 he worked from home, did not go so for next four days (from 24Dec2020 to 27Dec2020) he rested at home but his chills and body ache are not going away. They were there, they come and go, he took Tylenol, it went he have mild sore throat, cough on Dec2020. Today on 27Dec2020, the patient just took the temperature 100.7. For Causality assessment: Physician stated, "he didn't know, he was just trying to find out to get to bottom of it. Is it really COVID infection or is it due to side effects as from what he read the reaction shouldn't really last long. It may last probably 3-4 days but this has gone beyond that so he was little concerned and the fever that he had was 7 days after the vaccine." The patient still had chills and body ache which he means they were not going away and now mild fever. When probed for the outcome of, Physician stated, "They are persistent you know some day he had one day which was good but after that in the afternoon in the evening he felt the same thing. Fortunately, he was off for four days it didn't really have much problem, physically it was persistent has not gone away." Therapeutic measures were taken as a result of chills, had mild body ache, felt a little sick, cough, fever, mild sore throat. The outcome of events chills, mild body ache was not recovered. The outcome of the other events was unknown.

Other Meds: ; SYNTHROID

Current Illness:

ID: 0920197
Sex: F
Age:
State: MA

Vax Date: 12/22/2020
Onset Date: 12/27/2020
Rec V Date: 01/05/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: tested positive; tested positive; This is a spontaneous report from a contactable nurse reported for herself. A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection) via an unspecified route of administration on 22Dec2020 at single dose for Covid-19 immunization. The patient's medical history and concomitant medications were not reported. The patient got the COVID vaccine on 22Dec2020 and tested positive (COVID) on 27Dec2020, she didn't expect to be immune. The outcome of the event tested positive was unknown. Follow-up activities are possible, information on the batch number has been requested.; Sender's Comments: Based on the information currently available, a lack of efficacy with BNT162B2 in this patient cannot be completely excluded. Further information like specific SARS-CoV-2 test and any symptom associated with SARS-CoV-2 test positive needed for full medical assessment

Other Meds:

Current Illness:

Total 2021 VAERS Injuries: 599,999

Page last modified: 03 October 2021 5:28pm